Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Investment analysts at Wedbush decreased their FY2025 earnings estimates for Revolution Medicines in a research note issued to investors on Thursday, November 6th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($5.65) for the year, down from their prior estimate […]

Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Analysts at Wedbush decreased their FY2025 earnings estimates for Cartesian Therapeutics in a research note issued to investors on Thursday, November 6th. Wedbush analyst M. Fan now forecasts that the company will earn ($2.47) per share for the year, down from their previous estimate of ($1.47). The […]